355 related articles for article (PubMed ID: 8277200)
1. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease.
Edwards KM; Dupont WD; Westrich MK; Plummer WD; Palmer PS; Wright PF
J Infect Dis; 1994 Jan; 169(1):68-76. PubMed ID: 8277200
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience.
Neuzil KM; Dupont WD; Wright PF; Edwards KM
Pediatr Infect Dis J; 2001 Aug; 20(8):733-40. PubMed ID: 11734733
[TBL] [Abstract][Full Text] [Related]
3. Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.
Treanor JJ; Roth FK; Betts RF
J Clin Microbiol; 1990 Mar; 28(3):596-9. PubMed ID: 2182673
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
Belshe RB; Mendelman PM; Treanor J; King J; Gruber WC; Piedra P; Bernstein DI; Hayden FG; Kotloff K; Zangwill K; Iacuzio D; Wolff M
N Engl J Med; 1998 May; 338(20):1405-12. PubMed ID: 9580647
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
[TBL] [Abstract][Full Text] [Related]
6. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly.
Treanor JJ; Mattison HR; Dumyati G; Yinnon A; Erb S; O'Brien D; Dolin R; Betts RF
Ann Intern Med; 1992 Oct; 117(8):625-33. PubMed ID: 1530193
[TBL] [Abstract][Full Text] [Related]
7. In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory.
Powers DC; Fries LF; Murphy BR; Thumar B; Clements ML
J Clin Microbiol; 1991 Mar; 29(3):498-505. PubMed ID: 2037667
[TBL] [Abstract][Full Text] [Related]
8. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
Keitel WA; Cate TR; Nino D; Huggins LL; Six HR; Quarles JM; Couch RB
J Infect Dis; 2001 Jan; 183(2):329-332. PubMed ID: 11110645
[TBL] [Abstract][Full Text] [Related]
9. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
[TBL] [Abstract][Full Text] [Related]
10. Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren.
Khan AS; Polezhaev F; Vasiljeva R; Drinevsky V; Buffington J; Gary H; Sominina A; Keitel W; Regnery H; Lonskaya NL; Doroshenko E; Gavrilov A; Ivakhov I; Arden N; Schonberger LB; Couch R; Kendal A; Cox N
J Infect Dis; 1996 Feb; 173(2):453-6. PubMed ID: 8568310
[TBL] [Abstract][Full Text] [Related]
11. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.
Beyer WE; Palache AM; de Jong JC; Osterhaus AD
Vaccine; 2002 Jan; 20(9-10):1340-53. PubMed ID: 11818152
[TBL] [Abstract][Full Text] [Related]
12. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
Belshe RB; Gruber WC; Mendelman PM; Mehta HB; Mahmood K; Reisinger K; Treanor J; Zangwill K; Hayden FG; Bernstein DI; Kotloff K; King J; Piedra PA; Block SL; Yan L; Wolff M
J Infect Dis; 2000 Mar; 181(3):1133-7. PubMed ID: 10720541
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects.
Treanor JJ; Betts RF
Vaccine; 1998 Nov; 16(18):1756-60. PubMed ID: 9778752
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of inactivated and live attenuated influenza vaccines.
Monto AS; Ohmit SE; Petrie JG; Johnson E; Truscon R; Teich E; Rotthoff J; Boulton M; Victor JC
N Engl J Med; 2009 Sep; 361(13):1260-7. PubMed ID: 19776407
[TBL] [Abstract][Full Text] [Related]
15. Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study.
Gruber WC; Campbell PW; Thompson JM; Reed GW; Roberts B; Wright PF
J Infect Dis; 1994 Feb; 169(2):241-7. PubMed ID: 8106759
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.
Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM
J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042
[TBL] [Abstract][Full Text] [Related]
17. Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care Center.
Clements ML; Makhene MK; Karron RA; Murphy BR; Steinhoff MC; Subbarao K; Wilson MH; Wright PF
J Infect Dis; 1996 Jan; 173(1):44-51. PubMed ID: 8537681
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50-64 years of age.
DiazGranados CA; Saway W; Gouaux J; Baron M; Baker J; Denis M; Jordanov E; Landolfi V; Yau E
Vaccine; 2015 Dec; 33(51):7188-7193. PubMed ID: 26555348
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of inactivated influenza virus vaccine in young children in 2003-2004.
Mitchell DK; Ruben FL; Gravenstein S
Pediatr Infect Dis J; 2005 Oct; 24(10):925-7. PubMed ID: 16220095
[TBL] [Abstract][Full Text] [Related]
20. Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virus.
Feldman S; Wright PF; Webster RG; Roberson PK; Mahoney J; Thompson J; Doolittle M; Lott L; Johnson P; Christoph RC
J Infect Dis; 1985 Dec; 152(6):1212-8. PubMed ID: 3905983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]